Skip to main content

Table 1 Clinical and biochemical characteristics of the study subjects

From: Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease

Clinical parameters Control (NGT) T2DM CAD T2DM_CAD
n = 61 n = 60 n = 23 n = 21
Age (Years) 39.6 ± 13.7 56.4 ± 13.9a*** 38.7 ± 15.8 60.9 ± 10.7c***
Body mass index (kg/m2) 23.19 ± 4.8 25.5 ± 5.2 21.1 ± 4.3 23.2 ± 4
Systolic BP (mm Hg) 114 ± 9.5 125 ± 2.2a** 122.5 ± 20.6 142.4 ± 19.9b**c**
Diastolic BP (mm Hg) 74.98 ± 8.5 77.2 ± 9.0 71.8 ± 10.03 87.3 ± 11.04b*
Fasting plasma glucose (mg/dL) 84.9 ± 9.1 158.9 ± 67.5a*** 85.8 ± 12.5 136.2 ± 41.4c***
Glycated haemoglobin (%) 5.3 ± 0.37 8.5 ± 1.9a*** 5.4 ± 0.5 7.6 ± 0.8c**
Total serum cholesterol (mg/dL) 174.5 ± 34.08 173.3 ± 46.02 188.2 ± 81.2 182.3 ± 37.1
Serum triglycerides (mg/dL) 108.2 ± 51.1 168.4 ± 100.4a*** 105.1 ± 54.6 140.1 ± 77.4
HDL-cholesterol (mg/dL) 43 ± 7.9 40 ± 9.1 47.7 ± 12.6 41.9 ± 11.9
LDL-cholesterol (mg/dL) 107.7 ± 28.7 98.5 ± 37.9 119.5 ± 73.4 112.4 ± 33.3
VLDL-cholesterol (mg/dL) 20.2 ± 9.4 49.6 ± 51.5a*** 20.9 ± 10.8 23.5 ± 11.4
Urea 20.5 ± 5.2 23.5 ± 8.7 20.8 ± 5.7 22.3 ± 4.1
Creatinine 0.85 ± 0.16 4.6 ± 11.7 0.8 ± 0.16 0.8 ± 0.24
Microalbuminuria (mg/dL) 16.4 ± 48.4 22.1 ± 33.9 15.1 ± 20.2 15 ± 16.4
  1. For all the parameters mean ± SD is reported. aComparison between Control and T2DM, bComparison between T2DM and T2DM-CAD, cComparison between CAD and T2DM-CAD. *P < 0.05, **P < 0.01, ***P < 0.0001.